Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Levofloxacin Hemihydrate prices in Germany, the highest-cost reporting region, rose 8.0% in H1 2026, climbing from USD 74.7/KG in Q1 to USD 80.7/KG by Q2 as spring community-acquired respiratory infection and urinary tract infection treatment procurement and firmer fluoroquinolone synthesis feedstock costs drove consistent buying following the brief Q1 2026 pricing moderation. Globally, the average rose from USD 51.98/KG in Q1 to USD 56.14/KG in Q2, an 8.0% gain. For H2 2026, a global average of USD 56.80-62.50/KG is expected, with continued firming on Middle East supply disruptions and growing respiratory and urinary tract infection treatment sector demand globally.
Levofloxacin Hemihydrate is the L-stereoisomeric form of ofloxacin, a third-generation fluoroquinolone antibiotic produced by multi-step chemical synthesis from tetrafluorophthalic acid or similar fluorinated benzene precursors through pyridine ring formation, nucleophilic aromatic substitution, and stereospecific resolution or asymmetric synthesis steps to yield the pure L-form as a stable hemihydrate crystalline pharmaceutical grade. The compound exerts its bactericidal activity by dual inhibition of bacterial type II topoisomerase enzymes, specifically DNA gyrase and DNA topoisomerase IV, preventing relaxation of supercoiled DNA and disrupting replication, transcription, and repair in susceptible Gram-positive, Gram-negative, and atypical organisms. The largest pull comes from community-acquired pneumonia and acute bacterial exacerbation of chronic obstructive pulmonary disease treatment, where its broad spectrum and once-daily dosing convenience support high prescribing volumes. Urinary tract infection treatment including uncomplicated and complicated UTI and chronic bacterial prostatitis, skin and soft tissue infection management, and anthrax post-exposure prophylaxis add further demand. Synthesis feedstock costs, respiratory and UTI prescription volumes, and regional API production capacity all feed into the price.
The balance of supply and demand for Levofloxacin Hemihydrate through H2 2026 leans moderately firm. Fluoroquinolone synthesis feedstock costs firmed from Middle East chemical supply disruptions. Respiratory infection treatment procurement, UTI management, and antibiotic stewardship programme distribution are growing with expanding healthcare access.
The main upside risk is synthesis feedstock cost increases alongside a respiratory illness surge and expanded antibiotic access programme procurement. The main downside risk is continued Chinese API surplus and generic competition limiting the global price recovery.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 56.80 - 62.50 | Synthesis cost firming and respiratory/UTI demand support |
| United States | 60.60 - 66.30 | Steady respiratory and UTI demand holds firm |
| China | 43.60 - 49.30 | Large API capacity keeps it the most affordable |
| Germany | 81.20 - 86.90 | High synthesis and energy costs keep it the most expensive |
| India | 59.50 - 65.20 | Growing respiratory and export Rx demand holds a firm middle |
US Levofloxacin Hemihydrate prices averaged USD 65.2/KG in Q2 2026, up 7.9% from USD 60.4/KG in Q1 2026. Firmer synthesis feedstock costs and spring respiratory and UTI treatment procurement drove consistent buying following the Q1 moderation.
Why did the price of Levofloxacin Hemihydrate change in Q2 2026 in the United States?
Firmer fluoroquinolone synthesis feedstock costs raised the API production floor. Community-acquired pneumonia, UTI, and chronic bacterial prostatitis treatment procurement lifted buying. Anthrax prophylaxis and skin infection demand provided additional support near USD 65.2/KG.
Chinese Levofloxacin Hemihydrate prices averaged USD 46.2/KG in Q2 2026, up 7.9% from USD 42.8/KG in Q1 2026, the lowest among the tracked markets. Spring respiratory and UTI export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the production floor despite domestic API capacity.
Why did the price of Levofloxacin Hemihydrate change in Q2 2026 in China?
Spring respiratory infection and UTI treatment export and domestic procurement lifted buying. Firmer domestic fluoroquinolone synthesis costs raised the production floor. Domestic API capacity kept China the most affordable source.
German Levofloxacin Hemihydrate prices averaged USD 80.7/KG in Q2 2026, up 8.0% from USD 74.7/KG in Q1 2026, the highest among the tracked markets. Higher synthesis feedstock and energy costs elevated European API production economics. Consistent respiratory infection, UTI, and prostatitis treatment demand maintained steady buying.
Why did the price of Levofloxacin Hemihydrate change in Q2 2026 in Germany?
Higher fluoroquinolone synthesis feedstock and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to aromatic synthesis substrate supply chains. Consistent respiratory, UTI, and prostatitis treatment procurement maintained buying near USD 80.7/KG.
Indian Levofloxacin Hemihydrate prices averaged USD 62.7/KG in Q2 2026, up 7.9% from USD 58.1/KG in Q1 2026. Growing respiratory and UTI export and domestic demand supported buying. Firmer synthesis import costs raised the production floor through the quarter.
Why did the price of Levofloxacin Hemihydrate change in Q2 2026 in India?
Growing respiratory and UTI treatment export and domestic procurement lifted buying. Firmer fluoroquinolone synthesis import costs raised the production floor. Southeast Asian and African antibiotic export demand provided additional buying support near USD 62.7/KG.
US Levofloxacin Hemihydrate prices averaged USD 60.4/KG in Q1 2026, easing about 1.0% from Q4 2025. Post-quarter respiratory and UTI procurement moderation and soft synthesis costs eased the market before the Q2 spring season surge.
Why did the price of Levofloxacin Hemihydrate change in Q1 2026 in the United States?
Post-quarter respiratory and UTI treatment procurement moderation reduced buying urgency. Soft synthesis feedstock costs eased the production floor. The market eased to USD 60.4/KG before the Q2 spring respiratory infection treatment procurement surge.
Chinese prices averaged USD 42.8/KG in Q1 2026, easing about 0.9% from Q4 2025. Post-Lunar New Year procurement moderation and soft synthesis costs held the market near USD 42.8/KG.
Why did the price of Levofloxacin Hemihydrate change in Q1 2026 in China?
Post-Lunar New Year respiratory and UTI procurement moderation reduced urgency. Soft domestic synthesis costs eased the production floor. The market eased to USD 42.8/KG before the Q2 recovery.
German prices averaged USD 74.7/KG in Q1 2026, easing about 1.1% from Q4 2025. Post-winter respiratory procurement moderation and soft synthesis costs eased the market near USD 74.7/KG.
Why did the price of Levofloxacin Hemihydrate change in Q1 2026 in Germany?
Post-winter respiratory and UTI procurement moderation reduced urgency. Soft synthesis feedstock and energy costs eased the production floor. The market eased to USD 74.7/KG before the Q2 spring procurement surge.
Indian prices averaged USD 58.1/KG in Q1 2026, easing about 1.0% from Q4 2025. Post-quarter procurement moderation and soft synthesis import costs held the market near USD 58.1/KG.
Why did the price of Levofloxacin Hemihydrate change in Q1 2026 in India?
Post-quarter respiratory and UTI procurement moderation reduced buying urgency. Soft synthesis import costs eased the production floor. The market eased to USD 58.1/KG before the Q2 spring surge.
Global Levofloxacin Hemihydrate prices followed an alternating pattern, dipping in Q3 2025 and Q1 2026 on seasonal procurement moderation before recovering in Q4 2025 and surging in Q2 2026. The average eased from USD 52.0/KG in Q2 2025 to USD 51.48/KG in Q3, recovered to USD 52.51/KG in Q4, eased to USD 51.98/KG in Q1 2026, then surged to USD 56.14/KG in Q2 2026, a net gain of about 8.0% over the window. Fluoroquinolone synthesis feedstock cost cycles and respiratory and UTI treatment procurement seasonality drove the alternating pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 56.14 | +8.0% | ↑ Rising |
| Q1 2026 | 51.98 | -1.0% | ↓ Falling |
| Q4 2025 | 52.51 | +2.0% | ↑ Rising |
| Q3 2025 | 51.48 | -1.0% | ↓ Falling |
| Q2 2025 | 52.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Levofloxacin Hemihydrate prices firmed modestly through 2025 on consistent respiratory and UTI treatment demand. The global average opened near USD 51.8/KG in Q1 2025 and closed at USD 52.51/KG in Q4, a full-year gain of about 1.4%. Fluoroquinolone synthesis cost dynamics and respiratory infection procurement seasonality drove the quarterly oscillation throughout the year.
US prices firmed from about USD 60.5/KG in Q1 2025 to USD 61.0/KG by Q4, a gain of 0.8%. Consistent respiratory infection and UTI treatment demand maintained the modest upward trend through the year.
Chinese prices firmed from roughly USD 42.0/KG in Q1 2025 to USD 43.2/KG by Q4, a gain of 2.9%. Growing export respiratory and UTI treatment procurement drove the firming despite domestic API capacity.
German prices firmed from about USD 74.5/KG in Q1 2025 to USD 75.5/KG by Q4, a gain of 1.3%. Consistent respiratory, UTI, and prostatitis treatment demand and firm synthesis costs supported the market.
Indian prices firmed from roughly USD 57.8/KG in Q1 2025 to USD 58.7/KG by Q4, a gain of 1.6%. Growing respiratory and UTI export and domestic demand drove modest firming through the year.
Expert Market Research: Your Source for Real-Time Levofloxacin Hemihydrate Price Intelligence
Expert Market Research tracks Levofloxacin Hemihydrate prices continuously across every major producing and consuming region. The team traces causation through fluoroquinolone synthesis feedstock economics, respiratory and UTI treatment procurement cycles, and regional API production capacity. Contact Expert Market Research today for Levofloxacin Hemihydrate pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Community-acquired pneumonia and acute bacterial exacerbation of COPD takes the largest share, exploiting its broad spectrum and once-daily convenience. Urinary tract infection including complicated UTI and chronic bacterial prostatitis, skin and soft tissue infection management, and anthrax post-exposure prophylaxis also consume significant volumes globally.
The Q2 2026 average was USD 65.2/KG in the United States, USD 46.2/KG in China, USD 80.7/KG in Germany, and USD 62.7/KG in India. Germany remains the highest-priced market.
The global average rose from USD 51.98/KG in Q1 to about USD 56.14/KG in Q2, a gain of around 8.0%. Spring respiratory and UTI treatment procurement and firmer fluoroquinolone synthesis costs drove the H1 2026 surge.
Respiratory and urinary tract infection treatment procurement season cycles create alternating quarterly buying patterns. Post-season procurement moderation in Q1 and Q3 creates dips while spring and year-end respiratory and UTI procurement surges drive upticks.
The global average is expected in the USD 56.80 to 62.50/KG range for H2 2026, with continued firming as synthesis feedstock costs stay elevated and respiratory and UTI treatment demand grows globally.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on respiratory and UTI demand, and China prices lowest on domestic fluoroquinolone API production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to fluoroquinolone synthesis feedstock costs, respiratory infection season intensity and UTI treatment volumes, and Chinese API production discipline. Respiratory illness surveillance data and aromatic synthesis substrate prices are key signals.
China and India hold the largest levofloxacin API production capacity. Any fluoroquinolone synthesis feedstock cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time respiratory and UTI formulation contracts around synthesis cost and infection season cycles, build cover when feedstock signals tighten, and monitor respiratory illness data as the primary demand signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.